南方医科大学学报
南方醫科大學學報
남방의과대학학보
JOURNAL OF SOUTHERN MEDICAL UNIVERSITY
2015年
6期
844-847
,共4页
陈斯泽%陈雪梅%李玉齐%杨曙%莫贤毅%张帆%莫凯岚%丁颖
陳斯澤%陳雪梅%李玉齊%楊曙%莫賢毅%張帆%莫凱嵐%丁穎
진사택%진설매%리옥제%양서%막현의%장범%막개람%정영
食管癌%17-AAG%紫杉醇%增殖%凋亡
食管癌%17-AAG%紫杉醇%增殖%凋亡
식관암%17-AAG%자삼순%증식%조망
esophageal cancer%17-AAG%paclitaxel%proliferation%apoptosis
目的:研究17-AAG联合紫杉醇(PTX)对食管癌细胞Eca-109增殖和凋亡的影响。方法予以PTX和17-AAG单独或联合使用作用于Eca-109细胞株,采用MTT法检测其细胞增殖的变化,应用流式细胞仪检测细胞周期、凋亡的变化。结果与对照组相比,单独使用17-AAG、PTX均能够抑制Eca-109细胞的增殖;0.5μmol/L PTX联合0.625μmol/L 17-AAG可抑制Eca-109的生长,且联合效应明显强于各自单药组(P<0.01);流式细胞仪检测结果显示:17-AAG将Eca-109细胞阻滞于G2/M期,PTX将Eca-109细胞阻滞于S期。17-AAG与PTX联合用药使Eca-109细胞阻滞于G2/M期和S。17-AAG组、PTX组及联合组作用Eca-109细胞株24 h后其凋亡率分别为4.52%、10.91%、29.88%,显著高于对照组(1.32%);联合用药后,可形成明显凋亡峰,明显高于单药组。结论 PTX和17-AAG均可抑制食管癌细胞增殖,诱导癌细胞凋亡,两者联合可增强上述作用。
目的:研究17-AAG聯閤紫杉醇(PTX)對食管癌細胞Eca-109增殖和凋亡的影響。方法予以PTX和17-AAG單獨或聯閤使用作用于Eca-109細胞株,採用MTT法檢測其細胞增殖的變化,應用流式細胞儀檢測細胞週期、凋亡的變化。結果與對照組相比,單獨使用17-AAG、PTX均能夠抑製Eca-109細胞的增殖;0.5μmol/L PTX聯閤0.625μmol/L 17-AAG可抑製Eca-109的生長,且聯閤效應明顯彊于各自單藥組(P<0.01);流式細胞儀檢測結果顯示:17-AAG將Eca-109細胞阻滯于G2/M期,PTX將Eca-109細胞阻滯于S期。17-AAG與PTX聯閤用藥使Eca-109細胞阻滯于G2/M期和S。17-AAG組、PTX組及聯閤組作用Eca-109細胞株24 h後其凋亡率分彆為4.52%、10.91%、29.88%,顯著高于對照組(1.32%);聯閤用藥後,可形成明顯凋亡峰,明顯高于單藥組。結論 PTX和17-AAG均可抑製食管癌細胞增殖,誘導癌細胞凋亡,兩者聯閤可增彊上述作用。
목적:연구17-AAG연합자삼순(PTX)대식관암세포Eca-109증식화조망적영향。방법여이PTX화17-AAG단독혹연합사용작용우Eca-109세포주,채용MTT법검측기세포증식적변화,응용류식세포의검측세포주기、조망적변화。결과여대조조상비,단독사용17-AAG、PTX균능구억제Eca-109세포적증식;0.5μmol/L PTX연합0.625μmol/L 17-AAG가억제Eca-109적생장,차연합효응명현강우각자단약조(P<0.01);류식세포의검측결과현시:17-AAG장Eca-109세포조체우G2/M기,PTX장Eca-109세포조체우S기。17-AAG여PTX연합용약사Eca-109세포조체우G2/M기화S。17-AAG조、PTX조급연합조작용Eca-109세포주24 h후기조망솔분별위4.52%、10.91%、29.88%,현저고우대조조(1.32%);연합용약후,가형성명현조망봉,명현고우단약조。결론 PTX화17-AAG균가억제식관암세포증식,유도암세포조망,량자연합가증강상술작용。
Objective To investigate the effect of 17-AAG combined with paclitaxel (PTX) on the proliferation and apoptosis of esophageal squamous cell carcinoma cell line Eca-109 in vitro. Methods Eca-109 cells were treated with 17-AAG and PTX either alone or in combination. The proliferation of Eca-109 cells was detected by MTT assay, and the cell cycle changes and cell apoptosis were determined by flow cytometry. Results Compared with the control group, both 17-AAG and PTX significantly inhibited the proliferation of Eca-109 cells. A combined treatment of the cells with 0.5μmol/L PTX and 0.625μmol/L 17-AAG produced an obviously stronger inhibitory effect on the cell proliferation than either of the agents used alone (P<0.01). Flow cytometry showed that, 17-AAG and PTX used alone caused Eca-109 cell cycle arrest in G2/M phase and S phase, respectively, and their combined use caused cell cycle arrest in both G2/M and S phases. The cell apoptosis rates of Eca-109 cells treated with 17-AAG, PTX and their combination were 4.52%, 10.91%, and 29.88%, respectively, all significantly higher than that in the control group (1.32%); the combined treatment resulted in a distinct apoptotic peak that was significantly higher than that caused by either of the agents alone. Conclusion 17-AAG and PTX can inhibit cell proliferation and promote apoptosis of Eca-109 cells, and their combination produces stronger effects in inhibiting cell proliferation and increasing cell apoptosis.